semaglutide im Novo Nordisk to Seek Approval for Pill to Treat Diabetes in Young Patients Has anyone else started on

In this trial, 17,604 patients were enrolled to receive semaglutide 2.4 mg weekly or placebo and followed for approximately 36 months

During this window, nausea is the most commonly reported symptom, affecting roughly 40% of patients in clinical trials

These trials, including the PIONEER (Peptide Innovation for Early Diabetes Treatment) 2 trial, used oral semaglutide rather than injectable semaglutide and found that standard doses of up to 14 milligrams (mg) of oral semaglutide were safe and effective when combined with daily metformin doses of at least 1,500 mg

10.1016/j.bbi.2020.10.014 98 SunH.ShuJ.TangJ.LiY.QiuJ.DingZ.et al (2024)